5.07Open3.75Pre Close40 Volume891 Open Interest55.00Strike Price20.18KTurnover166.77%IV2.79%PremiumDec 6, 2024Expiry Date4.74Intrinsic Value100Multiplier2DDays to Expiry1.40Extrinsic Value100Contract SizeAmericanOptions Type-0.7250Delta0.0492Gamma8.67Leverage Ratio-0.4965Theta-0.0026Rho-6.28Eff Leverage0.0136Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet